SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-007231
Filing Date
2021-10-13
Accepted
2021-10-13 17:15:39
Documents
31
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insd_10q.htm   iXBRL 10-Q 307218
2 CERTIFICATION insd_ex311.htm EX-31.1 9702
3 CERTIFICATION insd_ex321.htm EX-32.1 4248
  Complete submission text file 0001477932-21-007231.txt   1297915

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA insd-20210831.xsd EX-101.SCH 15290
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE insd-20210831_lab.xml EX-101.LAB 90421
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insd-20210831_cal.xml EX-101.CAL 16928
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insd-20210831_pre.xml EX-101.PRE 77464
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insd-20210831_def.xml EX-101.DEF 31466
9 EXTRACTED XBRL INSTANCE DOCUMENT insd_10q_htm.xml XML 105869
Mailing Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218
Business Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218 800-542-8715
Instadose Pharma Corp. (Filer) CIK: 0001697587 (see all company filings)

IRS No.: 813599639 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 333-216292 | Film No.: 211321889
SIC: 2510 Household Furniture